Inflammatory bowel disease. Experience in 316 patients;Enfermedad inflamatoria intestinal a partir de una experiencia local

Revista Medica de Chile

Volumn 142, Issue 8, 2014, Pages 1006-1013

  Simian, Daniela ^a   Estay, Camila ^a   Lubascher, Jaime ^a   Acuña, Raúl ^a   Kronberg, Udo ^a   Figueroa, Carolina ^a   Brahm, Javier ^a   Silva, Guillermo ^a   López Köstner, Francisco ^a   Wainstein, Claudio ^a   Larach, Andrés ^a   Larach, Jorge ^a   Quera, Rodrigo ^a  

^a CLÍNICA LAS CONDES   (Chile)

Author keywords

Colitis ulcerative; Crohn disease; Inflammatory bowel disease; Trends

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILE; COHORT ANALYSIS; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; CHILE; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84928155141     PISSN: 00349887     EISSN: 07176163     Source Type: Journal    
DOI: 10.4067/S0034-98872014000800008     Document Type: Article

References (30)

1. Schirbel A, Fiocchi C. Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy. J Dig Dis 2010: 11: 266-76.
2. Sepúlveda SE, Beltrán CJ, Peralta A, Rivas P, Rojas N, Figueroa C, et al. Enfermedad inflamatoria intestinal: Una mirada inmunológica. Rev Med Chile 2008; 136: 367-75.
3. Molodecky NA, Soon IS, Rabi DM, Ghali WA, Ferris M, Chernoff G. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 2012; 142: 46-54.
4. Ng SC, Tang W, Ching JY, Wong M, Chow CM, Hui AJ. Incidence and phenotype of inflammatory bowel disease based on results from the Asia-pacific Crohn's and colitis epidemiology study. Gastroenterology 2013; 145: 158-65.
5. Petritsch W, Fuchs S, Berghold A, Bachmaier G, Högenauer C, Hauer AC, et al. Incidence of inflammatory bowel disease in the province of Styria, Austria, from 1997 to 2007: a population-based study. J Crohns Colitis 2013; 7: 58-69.
6. Burisch J, Munkholm P. Inflammatory bowel disease epidemiology. Curr Opin Gastroenterol 2013; 29: 357- 62.
7. Ouakaa-Kchaou A, Gargouri D, Bibani N, Elloumi H, Kochlef A, Kharrat J. Epidemiological evolution of epidemiology of the inflammatory bowel diseases in a hospital of Tunis. Tunis Med 2013; 91: 70-3.
8. Romberg-Camps MJ, Hesselink-van de Kruijs MA, Schouten LJ, Dagnelie PC, Limonard CB, Kester AD, et al. Inflammatory Bowel Disease in South Limburg (the Netherlands) 1991-2002: Incidence, diagnostic delay, and seasonal variations in onset of symptoms. J Crohns Colitis 2009; 3: 115-24.
9. Victoria CR, Sassak LY, Nunes HR. Incidence and prevalence rates of inflammatory bowel diseases, in midwestern of São Paulo State, Brazil. Arq Gastroenterol 2009; 46: 20-5.
10. Yepes I, Carmona R, Díaz F, Marín-Jiménez I. Prevalence and demographic characteristics of inflammatory bowel disease in Cartagena, Colombia. Rev Col Gastroenterol 2010; 25: 106-9.
11. Appleyard CB, Hernández G, Rios-Bedoya CF. Basic epidemiology of inflammatory bowel disease in Puerto Rico. Inflamm Bowel Dis 2004; 10: 106-11.
12. Quintana C, Galleguillos L, Benavides E, Quintana JC, Zúñiga A, Duarte I, et al. Clinical diagnostic clues in Crohn's disease: a 41-year experience. ISRN Gastroenterol 2012; 285475.
13. Linares de la Cal JA, Cantón C, Hermida C, Pérez- Miranda M, Maté-Jiménez J. Estimated incidence of inflammatory bowel disease in Argentina and Panama (1987-1993). Rev Esp Enferm Dig 1999; 91: 277-86.
14. Figueroa C, Quera R, Valenzuela J, Jensen C. Enfermedades inflamatorias intestinales: Experiencia de dos centros chilenos. Rev Med Chile 2005; 133: 1295-304.
15. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006; 55: 749-53.
16. Cosnes J, Gower-Rousseau C, Seksik P, Cortot A. Epidemiology and natural history of inflammatory bowel diseases. Gastroenterology 2011; 140: 1785-94.
17. Arin A, Borda F, Burusco MJ, Prieto C, Martínez A, Elizalde I, et al. Altas tasas de incidencia de enfermedad inflamatoria intestinal en Navarra. Resultados de un estudio prospectivo y poblacional. Gastroenterol Hepatol 2008; 31: 111-6.
18. Zeng Z, Zhu Z, Yang Y, Ruan W, Peng X, Su Y. Incidence and clinical characteristics of inflammatory bowel disease in a developed region of Guangdong Province, China: a prospective population-based study. J Gastroenterol Hepatol 2013; 28: 1148-53.
19. Gower-Rousseau C, Vasseur F, Fumery M, Savoye G, Salleron J, Dauchet L, et al. Epidemiology of inflammatory bowel diseases: new insights from a French populationbased registry (EPIMAD). Dig Liver Dis 2013; 45: 89-94.
20. Bernstein CN, Wajda A, Svenson LW, MacKenzie A, Koehoorn M, Jackson M, et al. The epidemiology of inflammatory bowel disease in Canada: a populationbased study. Am J Gastroenterol 2006; 101: 1559-68.
21. Burisch J, Pedersen N, Cukovic-Cavka S, Brinar M, Kaimakliotis I, Duricova D. East-West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort. Gut 2013; apr 20. [Epub ahead of print].
22. Fadda MA, Peedikayil MC, Kagevi I, Kahtani KA, Ben AA, Al HI, et al. Inflammatory bowel disease in Saudi Arabia: a hospital-based clinical study of 312 patients. Ann Saudi Med 2012; 32: 276-82.
23. Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease. World J Gastroenterol 2009; 15: 3504-10.
24. Lovasz BD, Lakatos L, Horvath A, Szita I, Pandur T, Mandel M, et al. Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a populationbased cohort. World J Gastroenterol 2013; 19: 2217-26.
25. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, et al. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-50.
26. Ordás I, Feagan B, Sandborn W. Early use of inmmunosuppressives or TNF antagonists for the treatment of Crohn's disease: time for a change. Gut 2011; 60: 1754- 63.
27. Ghazi L, Patil S, Rustgi A, Flasar M, Razeghi S, Cross R. Step up versus early biologic therapy for crohn's disease in clinical practice. Inflammatory Bowel Dis 2013; 19: 1397-403.
28. Langholz E, Munkholm P, Davidsen M, Binder V. Course of ulcerative colitis: analysis of changes in disease activity over years. Gastroenterology 1994; 107: 3-11.
29. Zvidi I, Fraser GM, Niv Y, Birkenfeld S. The prevalence of inflammatory bowel disease in an Israeli Arab population. J Crohns Colitis 2013; 7: e159-63.
30. Rungoe C, Langholz E, Andersson M, Basit S, Nielsen NM, Wohlfahrt J. Changes in medical treatment and surgery rates in inflammatory bowel disease: a nationwide cohort study 1979-2011. Gut. 2013; sep 20 [Epub ahead of print].